PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

New inquiry launched to assess impact of pandemic on pharmacy services

The All-Party Parliamentary Group on Pharmacy have launched an inquiry into the financial and operational impacts of the COVID-19 pandemic on pharmacy services in th...
Continue Reading →
News

Gilead and Novo Nordisk’s NASH trial meets primary endpoint

Gilead and Novo Nordisk have announced that a phase II proof-of-concept trial evaluating combination treatments for non-alcoholic steatohepatitis (NASH) met its prim...
Continue Reading →
News

Novartis’ Cosentyx reduces synovitis in new psoriatic arthritis study

Novartis’ interleukin-17A (IL-17A) Cosentyx (secukinumab) demonstrated early synovitis reduction in patients with active psoriatic arthritis in the phase IIIb ULTIMA...
Continue Reading →
News

Pfizer to build R&D facility in Wuhan, China

Pfizer is expanding its R&D efforts in China and announced plans to build a new facility.An agreement has been signed to establish a new Pfizer R&D centre in...
Continue Reading →
News

EU OK for AZ’s Calquence in CLL

The European Commission has approved AstraZeneca’s Calquence (acalabrutinib)for the treatment of adult patients with chronic lymphocytic leukaemia (CLL). Calquence...
Continue Reading →
News

Early data indicates Pfizer/BioNTech’s COVID-19 vaccine is 90% effective

A potential COVID-19 vaccine being developed by American pharma giant Pfizer and Germany-headquartered BioNTech is 90% effective, early data from a phase III trial s...
Continue Reading →
News

Waylivra, Tecentriq and more accepted by SMC

The Scottish Medicines Consortium has published guidance on eight new medicines, accepting seven of those and rejecting one for use by NHS Scotland in its November m...
Continue Reading →
News

UK study will evaluate aspirin as a potential COVID-19 treatment

Researchers from the UK’s RECOVERY study will evaluate the standard painkiller aspirin as a potential treatment for COVID-19 patients. The RECOVERY study will asse...
Continue Reading →
News

NICE recommends testing womb cancer patients for inherited condition

The UK’s National Institute for Health and Care Excellence (NICE) has released new guidance recommending that people with womb cancer should be tested for an inherit...
Continue Reading →
News

Blood test more predictive of ovarian cancer than ‘previously thought’

An already available blood test can better predict ovarian cancer than was previously thought, according to research published in PLOS Medicine yesterday. ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026